glp 1 meds tirzepatide FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price A Major GLP-1 Drug Shortage

Weight Loss Results: In a 48-week trial with people who had obesity: 12 mg dose: Average weight loss of 24.2% 8 mg dose: Average weight loss of 17.5% Placebo: Weight loss of 2.1% Let me put that in perspective: If you weigh 250 pounds: 24.2% weight loss = 60 pounds lost And people were still losing weight when the trial ended (no plateau reached yet) How this compares to other medications: Semaglutide (Wegovy): ~15% weight loss Tirzepatide (Zepbound): ~20% weight loss Retatrutide: ~24% weight loss This is the most significant weight loss we've seen with any medication to date

How Semaglutide Leads to Weight Loss So, how does all that translate into losing weight

The medication is profoundly effective for weight loss and metabolic health

Doing B12 injections at home adds flexibility, eliminates scheduling hassles, and puts you in charge of your wellness routine

Ulta Lab Tests provides convenient access to many cardiovascular, inflammation, metabolic, and oxidative-stress tests, allowing patients to gather objective information and prepare for more informed conversations with their healthcare providers